April 14, 2010
Michael Chu MD
Faculty peer reviewed
Case:
A 44-year old female presented to the emergency room with complaints of a lower extremity rash and swelling. The patient had been in her usual state of health when she presented to her primary care physician…
Read the rest of this entry >>
Posted in Endocrine
January 13, 2010
Sagar Mungekar
Faculty Peer Reviewed
The incidence of male pattern hair loss can reach almost 100% in some ethnic groups.1, 2 While treatment of the condition is usually deferred to dermatologists, it is often the primary care physician (PCP) who is first…
Read the rest of this entry >>
Posted in Class Act, Dermatology, Endocrine
December 2, 2009
Faculty peer reviewed
Are continuous glucose monitors the answer for better glucose control in diabetes?
A poorly controlled type 2 diabetic who is non-compliant with his at-home glucose monitoring comes to Bellevue’s Adult Primary Care Clinic requesting a prescription for a…
Read the rest of this entry >>
Posted in Endocrine
November 19, 2009
Arlene Chung
Faculty Peer Reviewed
Despite the high prevalence of obesity1 and its associated morbidity2 and mortality 3,4, it represents one of the most difficult chronic conditions to treat. Barriers include a metabolically toxic environment, a history of ill-fated weight-loss regimens, and a general…
Read the rest of this entry >>
Posted in Class Act, Clinical Questions, Endocrine
November 5, 2009
Kanika Ballani, Pharm.D.
Diana Hubulasvili, Pharm.D.
Developed by Amylin Pharmaceuticals, Exenatide (Byetta®) is an incretin mimetic that is used as an adjunctive therapy with metformin, a sulfonylurea or a thiazolidinedione to improve glycemic control in type 2 diabetic patients. Mechanistically, Exenatide mimics…
Read the rest of this entry >>
Posted in Breaking News, Endocrine, Pharmacology
September 16, 2009
David R. Friedmann MD
Faculty Peer Reviewed
Hemoglobin A1 (Hb A1c) is the standard method for monitoring diabetic patients’ long-term glycemic control by indicating average blood glucose levels over a period of two months, or half of the average life span of…
Read the rest of this entry >>
Posted in Class Act, Endocrine
March 26, 2009
Commentary by Melissa Price, MD PGY3
Faculty Peer Reviewed
A 42 year-old male phlebotomist with a history of anxiety presented to the emergency room complaining of four hours of dizziness and diaphoresis. He denied taking any medications. His vitals were stable, his…
Read the rest of this entry >>
Posted in Endocrine
December 26, 2008
Commentary by Regina Mysliwiec, NYU Medical Student
Faculty Peer Reviewed
G.L. is a 62 year-old African-American male with a six year history of Type 2 Diabetes with variable glucose control and a progressive one year history of burning pain in a unilateral…
Read the rest of this entry >>
Posted in Class Act, Endocrine, Neuro
September 25, 2008
Commentary by Howard Furst MD and Mitchell Charap MD
We will focus our review of the 2008 ADA meetings on new data regarding the GLP-1 analogues and the DPP 4 inhibitors. Before describing the clinical data, we will review the basic…
Read the rest of this entry >>
Posted in Endocrine, Meeting Perspectives
September 24, 2008
Commentary by Sarika Modi MD, PGY-2
Dr. Irwin Klein MD, Professor of Medicine and Cell Biology, of North Shore University Hospital, gave grand rounds on “Thyroid Disease and the Heart” on September 17, 2008. He began his talk by giving an…
Read the rest of this entry >>
Posted in Cardiology, Endocrine, Grand Rounds
August 20, 2008
Commentary by Rachana Jani MD, PGY-2
As recently reported in ShortCuts, Byetta recently made headlines after the suggestion of a mortality benefit for patients taking the drug in a small subset of the Accord study. So is this the new golden drug for diabetics? Perhaps not. This week,…
Read the rest of this entry >>
Posted in Breaking News, Endocrine
August 13, 2008
Commentary by Judith Brenner MD, Associate Editor, Clinical Correlations. Reviewed by Valerie Peck MD, NYU Division of Endocrinology.
An 81 year old Caucasian woman with a history of diabetes and hypertension who was admitted to the orthopedic service with a hip…
Read the rest of this entry >>
Posted in Endocrine
